Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Polymyalgia rheumatica/temporal arteritis: recent advances.

Maria-Louise Barilla-LaBarca1, Deborah J Lenschow, Richard D Brasington

  • 1Division of Rheumatology, Washington University School of Medicine, Box 8045, 660 S. Euclid Avenue, St. Louis, MO 63119, USA.

Current Rheumatology Reports
|January 19, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

ISG15 negatively regulates RIPK3-mediated cell death and viral pathogenesis.

Cell reports·2026
Same author

Stabilizing and strengthening the US physician-scientist faculty workforce in academic medicine: a proposed institutional framework.

JCI insight·2026
Same author

IFNs: Maestros of the Immune System.

Journal of immunology (Baltimore, Md. : 1950)·2024
Same author

Initiator cell death event induced by SARS-CoV-2 in the human airway epithelium.

Science immunology·2024
Same author

The differential role of SSa/SSb and Ro52 antibodies in defining clinical phenotypes in idiopathic inflammatory myopathies.

Seminars in arthritis and rheumatism·2024
Same author

A multidisciplinary approach to treating a unique case of recurrent metastatic thymic carcinoma: case report.

Therapeutic advances in rare disease·2023
Same journal

Intensive Care Management of ANCA-associated Vasculitides: a Narrative Review.

Current rheumatology reports·2026
Same journal

The Role of Musculoskeletal Ultrasound in Psoriatic Arthritis: From Preclinical Detection to Treatment Monitoring.

Current rheumatology reports·2026
Same journal

Correction to: Is Gout and Autoinflammatory Disease?

Current rheumatology reports·2026
Same journal

Risks and Management of Glucocorticoid Therapy for Patients with Rheumatic Disease Having Surgery.

Current rheumatology reports·2026
Same journal

Perioperative Management Considerations for Patients with Systemic Lupus Erythematosus.

Current rheumatology reports·2026
Same journal

Management of IgG4-Related Disease.

Current rheumatology reports·2026
See all related articles

Polymyalgia rheumatica and temporal arteritis affect older adults, often requiring steroid therapy. This review explores new treatments beyond steroids to manage persistent vascular inflammation and improve patient outcomes.

Area of Science:

  • Rheumatology
  • Internal Medicine
  • Vascular Inflammation

Background:

  • Polymyalgia rheumatica (PMR) and temporal arteritis (TA) are common inflammatory conditions in individuals over 50.
  • These diseases cause significant patient morbidity and are primarily managed with corticosteroids.

Purpose of the Study:

  • To review recent advancements in the clinical, epidemiological, and pathogenetic understanding of PMR/TA.
  • To evaluate the efficacy and limitations of current steroid-based treatments.
  • To explore and compare alternative therapeutic agents for PMR/TA.

Main Methods:

  • Literature review of recent trends in PMR/TA.
  • Analysis of clinical findings, epidemiology, and pathogenesis.
  • Comparison of steroid therapy with emerging alternative treatments.

Related Experiment Videos

Main Results:

  • Corticosteroids effectively suppress symptoms but do not fully resolve underlying vascular inflammation.
  • Steroids carry significant side effect burdens, especially in elderly patients.
  • Alternative agents are under investigation to address persistent inflammation and reduce steroid toxicity.

Conclusions:

  • Current steroid treatments for PMR/TA have limitations due to side effects and incomplete resolution of inflammation.
  • Further research into alternative therapies is crucial for improved long-term management of PMR/TA.
  • Optimizing treatment strategies may reduce morbidity and enhance quality of life for affected patients.